CONSOLIDATED STATEMENTS OF OPERATIONS (Parentheticals) - USD ($) |
12 Months Ended | |
|---|---|---|
Oct. 31, 2018 |
Oct. 31, 2017 |
|
| Research and Development Expense [Member] | ||
| Non-cash share-based compensation expenses | $ 4,596,866 | $ 288,187 |
| Selling, General and Administrative Expenses [Member] | ||
| Non-cash share-based compensation expenses | $ 4,298,748 | $ 1,388,585 |
| X | ||||||||||
- Definition Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|